In the early stage group, 69 patients showed high FOXC2 expression in tumor cells. Patients with high FOXC2 expression suffered from worse OS as compared to those with low FOXC2 expression (P = 0.03, Fig. 1c). Here, FOXC2 is linked to neoplasm.